HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Partial liquid ventilation with FC-77 suppresses the release of lipid mediators in rat acute lung injury model.

AbstractOBJECTIVE:
To investigate whether the release of lipid mediators is suppressed in rats with experimentally induced acute lung injury managed with partial liquid ventilation (PLV) using FC-77.
DESIGN:
Prospective, randomized controlled study.
SETTING:
Research laboratory in a university.
SUBJECTS:
Male Sprague-Dawley rats.
INTERVENTIONS:
After tracheostomy was performed under general anesthesia, lung injury was induced by intratracheal instillation of HCl. The PLV group was then subjected to conventional gas ventilation for 30 mins, followed by PLV using FC-77. The control group was subjected to conventional gas ventilation throughout the study period.
MEASUREMENTS AND MAIN RESULTS:
In the PLV group the following results were obtained: a) impaired oxygenation was markedly improved; b) the increase in the serum levels of lipid mediators such as leukotriene B4, thromboxane A2, and 6-keto-prostaglandin F1alpha was suppressed; and c) the increase in the concentrations of leukotriene B4, thromboxane A2, and 6-keto-prostaglandin F1alpha in the total lung homogenate at 180 mins after lung injury was also suppressed.
CONCLUSION:
This study indicates that PLV using FC-77 suppresses the release of lipid mediators in our rat model of acute lung injury. However, further investigation is needed to clarify the precise mechanism of this effect.
AuthorsYoh Hirayama, Hiroyuki Hirasawa, Shigeto Oda, Hidetoshi Shiga, Kenichi Matsuda, Hirokazu Ueno, Masataka Nakamura
JournalCritical care medicine (Crit Care Med) Vol. 32 Issue 10 Pg. 2085-9 (Oct 2004) ISSN: 0090-3493 [Print] United States
PMID15483418 (Publication Type: Evaluation Study, Journal Article)
Chemical References
  • Arachidonic Acids
  • Fluorocarbons
  • Inflammation Mediators
  • fluorocarbon 77
  • Leukotriene B4
  • Thromboxane A2
  • 6-Ketoprostaglandin F1 alpha
  • Hydrochloric Acid
Topics
  • 6-Ketoprostaglandin F1 alpha (biosynthesis)
  • Animals
  • Arachidonic Acids (biosynthesis)
  • Fluorocarbons (pharmacology, therapeutic use)
  • Hydrochloric Acid (adverse effects)
  • Inflammation Mediators (metabolism)
  • Leukotriene B4 (biosynthesis)
  • Liquid Ventilation (methods)
  • Male
  • Models, Animal
  • Rats
  • Rats, Sprague-Dawley
  • Respiratory Distress Syndrome (chemically induced, immunology, therapy)
  • Thromboxane A2 (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: